We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.5B
1-Year Est. Return 11.68%
This Fund
S&P 500
This Quarter Est. Return
+6.37%
1 Year Est. Return
+11.68%
3 Year Est. Return
+44.44%
5 Year Est. Return
+55.04%
10 Year Est. Return
+251.5%
AUM
$813M
AUM Growth
+$43.5M
Cap. Flow
-$1.72M
Cap. Flow %
-0.21%
Top 10 Hldgs %
20.71%
Holding
251
New
10
Increased
63
Reduced
107
Closed
7

Top Buys

Rank Stock Value
1
ADP icon
Automatic Data Processing
ADP
+$2.9M
2
AL
Air Lease Corp
AL
+$2.05M
3
IQV icon
IQVIA
IQV
+$1.92M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.89M
5
GE icon
GE Aerospace
GE
+$1.74M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$2.64M
2
MIDD icon
Middleby
MIDD
+$2.44M
3
GILD icon
Gilead Sciences
GILD
+$1.58M
4
ROK icon
Rockwell Automation
ROK
+$1.34M
5
AAPL icon
Apple
AAPL
+$1.04M

Sector Composition

Rank Sector Weight
1 Healthcare 17.01%
2 Industrials 14.02%
3 Technology 13.29%
4 Consumer Staples 10.45%
5 Financials 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALK icon
151
Alaska Air
ALK
$5.86B
$915K 0.11%
9,925
– –
LLY icon
152
Eli Lilly
LLY
$995B
$882K 0.11%
10,490
-75
-0.7% -$6.01K
IWO icon
153
iShares Russell 2000 Growth ETF
IWO
$15B
$824K 0.1%
5,100
– –
FTV icon
154
Fortive
FTV
$18.3B
$809K 0.1%
21,310
-7,275
-25% -$261K
ILMN icon
155
Illumina
ILMN
$30.7B
$792K 0.1%
4,774
– –
STWD icon
156
Starwood Property Trust
STWD
$6.03B
$790K 0.1%
34,967
-1,229
-3% -$27.7K
SDY icon
157
State Street SPDR S&P Dividend ETF
SDY
$23.8B
$783K 0.1%
8,880
-280
-3% -$24.5K
COP icon
158
ConocoPhillips
COP
$144B
$774K 0.1%
15,525
-250
-2% -$12.1K
VIG icon
159
Vanguard Dividend Appreciation ETF
VIG
$114B
$737K 0.09%
8,189
+255
+3% +$22.6K
FCX icon
160
Freeport-McMoran
FCX
$96.7B
$732K 0.09%
54,782
– –
ESRX
161
DELISTED
Express Scripts Holding Company
ESRX
$729K 0.09%
11,062
-1,937
-15% -$133K
BUD icon
162
AB InBev
BUD
$167B
$701K 0.09%
6,389
– –
IJH icon
163
iShares Core S&P Mid-Cap ETF
IJH
$126B
$698K 0.09%
20,375
-1,365
-6% -$46.5K
DNB
164
DELISTED
Dun & Bradstreet
DNB
$690K 0.08%
6,388
+150
+2% +$17K
ICUI icon
165
ICU Medical
ICUI
$4.3B
$687K 0.08%
4,500
– –
TER icon
166
Teradyne
TER
$63.1B
$687K 0.08%
+22,100
New +$632K
MDT icon
167
Medtronic
MDT
$110B
$680K 0.08%
8,435
-868
-9% -$67.8K
AVNT icon
168
Avient
AVNT
$3.5B
$678K 0.08%
19,894
-500
-2% -$16.8K
LNC icon
169
Lincoln National
LNC
$9B
$673K 0.08%
10,276
– –
BNY
170
Bank of New York Mellon
BNY
$106B
$654K 0.08%
13,850
– –
IWR icon
171
iShares Russell Mid-Cap ETF
IWR
$57.3B
$650K 0.08%
13,892
– –
COHR
172
DELISTED
Coherent Inc
COHR
$650K 0.08%
3,162
-478
-13% -$83.6K
ES icon
173
Eversource Energy
ES
$27.3B
$642K 0.08%
10,930
-975
-8% -$55.4K
TRV icon
174
Travelers Companies
TRV
$78.7B
$619K 0.08%
5,133
-150
-3% -$18K
TWX
175
DELISTED
Time Warner Inc
TWX
$586K 0.07%
6,000
– –
5 6
7
8 9

Similar funds

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
JFGLC
Johnson Financial Group LLC (Colorado) Denver, Colorado $1.5B AUM 16.09% 1-Year Est. Return
AAM
Aureus Asset Management Boston, Massachusetts $1.5B AUM 20.3% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
SCM
SG Capital Management Chicago, Illinois $1.51B AUM 49.98% 1-Year Est. Return
FMI
F/M Investments Washington, District of Columbia $1.51B AUM 25.86% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
RCW
Rheos Capital Works Tokyo, Japan $1.5B AUM 47.78% 1-Year Est. Return

Boston Family Office's Q1 2017 Portfolio in Review

As of Q1 2017, Boston Family Office held 251 positions worth $813M, up 5.6% from $770M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Boston Family Office's Q1 2017 filing shows 10 new, 63 increased, 107 reduced and 7 closed positions. Its largest new stake was Teradyne: 22,100 shares worth $687K. The largest sale was Teva Pharmaceuticals, an estimated $2.64M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 17% a quarter earlier, followed by Industrials and Technology.

  • Boston Family Office's largest Q1 2017 buy was Teradyne: 22,100 shares worth $687K.
  • Boston Family Office added most to Automatic Data Processing in Q1 2017, an estimated $2.9M increase.
  • Boston Family Office's biggest Q1 2017 reduction was Middleby, cutting an estimated $2.44M.
  • Boston Family Office fully exited Teva Pharmaceuticals in Q1 2017, selling an estimated $2.64M.
  • Boston Family Office's ten largest holdings make up 21% of its $813M portfolio in Q1 2017.
  • Boston Family Office opened 10 new positions and closed 7 in Q1 2017.
  • Boston Family Office's portfolio value rose 5.6% quarter-over-quarter to $813M.

Based on Boston Family Office's 13F filing for Q1 2017, filed 5 May 2017.